From Nextgov.com: FDA mulls regulating online claims, discussions about pharmaceuticals
Drug manufacturers and health care professionals attend a two-day hearing to discuss responsibility for reducing misinformation on the Internet.
While the Food and Drug Administration considers how to regulate drug marketing on the Web, it needs to realize much of the information on pharmaceuticals and therapies discussed on social networking sites is difficult to track, health professionals say.
NEXT STORY: Some Details on Hiring Reform